BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4869797)

  • 21. [Treatment of threatened abortion and premature labor with isoxsuprine hydrochloride].
    Scillieri P; Grossi F
    Arch Ostet Ginecol; 1971; 76(4):129-37. PubMed ID: 5153115
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
    Damianov L; Negentsov N; Ivanov S; Novachkov V; Tsachev K
    Akush Ginekol (Sofiia); 1995; 34(3):78-81. PubMed ID: 8743863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of uterine contraction in labor by prostaglandin antagonists in threatened abortion, premature labor and normal labor].
    Györy G; Kiss C; Benyó T; Bagdány S; Szalay J; Kurcz M; Virág S
    Orv Hetil; 1974 Sep; 115(36):2117. PubMed ID: 4212687
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interpretative analysis of 50 cases of tocolysis treated with isoxsuprine].
    Tomassini A; Razzini M; Zocchi G; Caprioli E
    Minerva Ginecol; 1975 Nov; 27(11):861-73. PubMed ID: 1103019
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical contribution on the use of delayed-action isoxsuprine in threatened abortion].
    Sola O; Colonna-Romano L
    Arch Ostet Ginecol; 1974; 79(5-6):326-35. PubMed ID: 4471560
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of the administration of tocopherol on threatened abortion, premature labor and toxemia of late pregnancy.
    Akasu F; Tateno M
    J Jpn Obstet Gynecol Soc; 1966 Apr; 13(2):91-7. PubMed ID: 5973837
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemorrhage during the 2nd half of pregnancy and premature labor in our case reports covering 7 years].
    Kliment V; Zachar V; Havran L; Benko J
    Cesk Gynekol; 1973 Jun; 38(3):304-5. PubMed ID: 4717855
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of beta-mimetics in threatened abortion or premature labor].
    J Gynecol Obstet Biol Reprod (Paris); 1977; 6(3):391-418. PubMed ID: 20460
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trial of Magnerot in the treatment of a threatened abortion after a previous delivery].
    Kavardzhikova S
    Akush Ginekol (Sofiia); 2000; 40(4):54-5. PubMed ID: 11288641
    [No Abstract]   [Full Text] [Related]  

  • 31. [Suppression of labor contractions by intravenous hexoprenaline: a preliminary investigation in the Paarl Hospital].
    De Villiers VP
    S Afr Med J; 1975 Mar; 49(10):345-8. PubMed ID: 234632
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vitamin K in obstetrics--effects of vitamin K1 on threatened abortion and premature labor].
    Hata Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Nov; 19(11):1398-401. PubMed ID: 5627227
    [No Abstract]   [Full Text] [Related]  

  • 33. [Causes of premature births].
    Wawryk R; Waroński W; Norska I; Piasecka M; Lukas A; Zelazny T
    Pol Tyg Lek; 1971 Mar; 26(12):436-8. PubMed ID: 5552279
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of Salbupart in the inhibition of uterine contractions in abortion and premature labor in comparison to Partusisten].
    Skorut S
    Wiad Lek; 1987 Jan; 40(2):86-9. PubMed ID: 3296465
    [No Abstract]   [Full Text] [Related]  

  • 35. [Condition of newborn infants from pregnancies threatened by abortion or premature labor treated by intravenous infusions of 10% ethanol].
    Czapla J
    Ginekol Pol; 1981 Mar; 52(3):241-4. PubMed ID: 7262585
    [No Abstract]   [Full Text] [Related]  

  • 36. Tocolytic therapy in obstetrics.
    Mosler KH; Linka F; Dornhöfer W; Ehrhart J
    J Perinat Med; 1974; 2(1):3-16. PubMed ID: 4157075
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of flavoxate in the treatment of threatened abortion and threatened premature labor].
    Capra A; Paggi G
    Minerva Ginecol; 1972; 24(8):400-4. PubMed ID: 4671849
    [No Abstract]   [Full Text] [Related]  

  • 38. [Terbutaline, a new inhibitor of the uterus].
    Vargas García C; Macedo García J; Ahued R; Lowenberg Favela E
    Ginecol Obstet Mex; 1974 Aug; 36(214):75-88. PubMed ID: 4430451
    [No Abstract]   [Full Text] [Related]  

  • 39. [100 clinical cases of pregnancy complications treated with a 19-nor-progesterone, registered as 31.458 Ba and followed until term].
    Lanvin M; Trévoux R; Binet M; Grand
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(2):110-7. PubMed ID: 5758414
    [No Abstract]   [Full Text] [Related]  

  • 40. [Our experience in using brikanil tokolytic therapy].
    Grigorov S; Despodova Ts; Serdev V
    Akush Ginekol (Sofiia); 1983; 22(4):273-7. PubMed ID: 6670698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.